ISHL HL Update 2021 | NHL following treatment for classical HL
Dennis Eichenauer
• 15 Mar 2021
Dennis Eichenauer, MD, University Hospital of Cologne, Cologne, Germany, talks on the incidence of non-Hodgkin lymphoma (NHL) following treatment for classical Hodgkin lymphoma (HL) as evaluated in a retrospective analysis from the German Hodgkin Study Group. In this analysis, it was observed that NHL after classical HL is a rare event primarily affecting older individuals and often resulting in the patients’ death. This interview took place at the Update on Hodgkin Lymphoma 2021, a Virtual ISHL event.
